Abstract:Head and neck squamous cell carcinoma (HNSCC) is currently one of the most common malignancies with a poor prognosis worldwide. Meanwhile, small ubiquitin‐like modifier (SUMO) specific peptidase 1 (SENP1) was associated with ferroptosis. However, the specific functions and underlying mechanisms of action of SENP1 in ferroptosis and tumor progression of HNSCC remain to be established. The findings of the present study implicated a novel ferroptosis pathway in the initiation and progression of HNSCC, providing new functional targets to guide future therapy. In the present study, The Cancer Genome Atlas database was employed to establish a gene model related to ferroptosis and verified SENP1 as a key gene via transcriptome sequencing. Expression of SENP1 in HNSCC tissue and CAL‐27 cells was detected based on reverse transcription‐quantitative PCR and western blot analysis. Proliferation and migration abilities of cells were determined using Cell Counting Kit‐8, wound healing and Transwell experiments. Expression levels of iron, glutathione (GSH) and lipid peroxidation end‐product malondialdehyde (MDA) under conditions of silencing of SENP1 with shRNA lentivirus were assayed. Additionally, the relationship between SENP1 and long‐chain acyl‐coenzyme A synthase 4 (ACSL4) was validated with the aid of immunoblotting and co‐immunoprecipitation (co‐IP). Finally, the influence of shSENP1 on the expression of key ferroptosis proteins, glutathione peroxidase 4 (GPX4) and solute carrier family 7 member 11, was evaluated via western blotting. It was revealed that SENP1 was significantly overexpressed in HNSCC and associated with low patient survival. Silencing of SENP1 led to significant suppression of cell proliferation, migration and invasion, increase in the contents of iron ions and MDA and decline in GSH levels in HNSCC cells, thereby enhancing ferroptosis and inhibiting disease progression. Conversely, overexpression of SENP1 suppressed ferroptosis and promoted progression of HNSCC. Co‐IP and western blot analyses revealed a SUMOylation link between SENP1 and ACSL4. SENP1 reduced the stability of ACSL4 protein through deSUMOylation, leading to inhibition of ferroptosis. SENP1 silencing further inhibited the expression of the key iron death protein, GPX4, to regulate ferroptosis. Taken together, SENP1 deficiency promoted ferroptosis and inhibited tumor progression through reduction of SUMOylation of ACSL4 in HNSCC. The collective results of the present study supported the utility of SENP1 as an effective predictive biomarker for targeted treatment of HNSCC.

Downregulation of SENP1 Inhibits Cell Proliferation, Migration and Promotes Apoptosis in Human Glioma Cells.

Down-regulation of SENP1 Expression Increases Apoptosis of Burkitt Lymphoma Cells

SENP1-Mediated deSUMOylation Regulates the Tumor Remodeling of Glioma Stem Cells Under Hypoxic Stress

SENP1-mediated SUMOylation of SIRT1 affects glioma development through the NF-κB pathway

SENP7 inhibits glioblastoma metastasis and invasion by dissociating SUMO2/3 binding to specific target proteins

Sumo-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells Via Regulating Smad4 Desumoylation

SUMO-specific Protease 1 Regulates the in Vitro and in Vivo Growth of Colon Cancer Cells with the Upregulated Expression of CDK Inhibitors.

589. SENP1 Knockdown Inhibits Hepatocyte Growth Factor-Induced Migration and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma

Suppressing SENP1 Inhibits Esophageal Squamous Carcinoma Cell Growth Via SIRT6 SUMOylation

SUMO-specific Protease 1 Promotes Prostate Cancer Progression and Metastasis.

Protein Sumoylation with SUMO1 Promoted by Pin1 in Glioma Stem Cells Augments Glioblastoma Malignancy.

SUMO-1 Gene Silencing Inhibits Proliferation and Promotes Apoptosis of Human Gastric Cancer SGC-7901 Cells

Knockdown of Cyclin D1 Inhibits Proliferation, Induces Apoptosis, and Attenuates the Invasive Capacity of Human Glioblastoma Cells

Down-Regulation of Neogenin Accelerated Glioma Progression Through Promoter Methylation and Its Overexpression in SHG-44 Induced Apoptosis

SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1

SENP1 Inhibition Induces Apoptosis and Growth Arrest of Multiple Myeloma Cells Through Modulation of NF-κB Signaling.

SENP1 Regulates Cell Migration and Invasion in Neuroblastoma.

Knockdown of NUSAP1 Inhibits Cell Proliferation and Invasion Through Down-Regulation of TOP2A in Human Glioblastoma

Sumoylation Negatively Regulates CSR1-Dependent Prostate Cancer Cell Death

Over-expression of Small Ubiquitin-Like Modifier Proteases 1 Predicts Chemo-Sensitivity and Poor Survival in Non-Small Cell Lung Cancer.

SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9